Lyra Therapeutics Inc
LYRA28.650USD
+23.720+481.14%
交易中 （美東）報價延遲15分鐘
1.89B總市值
虧損本益比TTM
關於 Lyra Therapeutics Inc 公司
Lyra Therapeutics, Inc. 是一家臨牀階段的生物技術公司。該公司專注於開發和商業化用於局部治療慢性鼻竇炎 (CRS) 患者的療法。該公司有兩種研究性候選產品 LYR-210 和 LYR-220，正處於針對 CRS 的後期開發階段，CRS 是一種常見的鼻旁竇炎症性疾病，會導致衰弱症狀和嚴重發病率。LYR-210 和 LYR-220 是生物可吸收的鼻植入物，旨在通過簡單的診室手術進行給藥，旨在爲鼻腔通道提供六個月的持續糠酸莫米松藥物治療。 LYR-210 專爲未接受過手術的患者設計，目前正在 ENLIGHTEN 第三期臨牀項目中進行評估，而 LYR-220 正在 BEACON 第二期臨牀試驗中進行評估，針對的是儘管曾接受過篩竇手術但仍有復發症狀的患者。
公司簡介
公司代碼LYRA
公司名稱Lyra Therapeutics Inc
上市日期May 01, 2020
成立日期2005
CEODr. Maria Palasis, Ph.D.
員工數量30
證券類型Ordinary Share
年結日May 01
公司地址480 Arsenal Way
城市WATERTOWN
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編02472
電話16173734600
網址https://lyratherapeutics.com/
公司代碼LYRA
上市日期May 01, 2020
成立日期2005
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Harlan W. Waksal, M.D.
Dr. Harlan W. Waksal, M.D.
Executive Chair and Chairperson of the Board
Executive Chair and Chairperson of the Board
10.74K
--
Dr. Nancy L. Snyderman, M.D.
Dr. Nancy L. Snyderman, M.D.
Independent Director
Independent Director
--
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Dr. Richard Nieman, M.D.
Dr. Richard Nieman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. James R (Jim) Tobin
Mr. James R (Jim) Tobin
Lead Independent Director
Lead Independent Director
--
--
Ms. C. Ann Merrifield
Ms. C. Ann Merrifield
Independent Director
Independent Director
--
--
Mr. W. Bradford Smith
Mr. W. Bradford Smith
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Harlan W. Waksal, M.D.
Dr. Harlan W. Waksal, M.D.
Executive Chair and Chairperson of the Board
Executive Chair and Chairperson of the Board
10.74K
--
Dr. Nancy L. Snyderman, M.D.
Dr. Nancy L. Snyderman, M.D.
Independent Director
Independent Director
--
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Dr. Richard Nieman, M.D.
Dr. Richard Nieman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. James R (Jim) Tobin
Mr. James R (Jim) Tobin
Lead Independent Director
Lead Independent Director
--
--
Ms. C. Ann Merrifield
Ms. C. Ann Merrifield
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
股東統計
佔比
Perceptive Advisors LLC
19.25%
North Bridge Venture Partners
8.89%
BlackRock Institutional Trust Company, N.A.
4.53%
The Vanguard Group, Inc.
2.66%
Samsara BioCapital, LLC
2.10%
Other
62.57%
持股股東
股東統計
佔比
Perceptive Advisors LLC
19.25%
North Bridge Venture Partners
8.89%
BlackRock Institutional Trust Company, N.A.
4.53%
The Vanguard Group, Inc.
2.66%
Samsara BioCapital, LLC
2.10%
Other
62.57%
股東類型
股東統計
佔比
Private Equity
19.25%
Venture Capital
10.98%
Investment Advisor
6.77%
Investment Advisor/Hedge Fund
6.14%
Hedge Fund
4.27%
Research Firm
0.88%
Individual Investor
0.83%
Pension Fund
0.24%
Bank and Trust
0.08%
Other
50.56%
機構持股
更新時間: 3月4日 週二
更新時間: 3月4日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
166
33.99M
51.29%
-25.72M
2024Q4
169
34.27M
52.36%
-23.86M
2024Q3
170
41.74M
67.36%
-17.33M
2024Q2
155
41.35M
70.46%
-15.27M
2024Q1
137
54.47M
94.92%
+4.29M
2023Q4
113
50.90M
93.69%
+8.93M
2023Q3
96
40.42M
84.31%
-314.10K
2023Q2
103
42.33M
88.17%
+11.26M
2023Q1
124
25.98M
81.63%
-890.12K
2022Q4
126
26.32M
82.72%
+975.89K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Perceptive Advisors LLC
12.76M
19.36%
--
--
Dec 31, 2024
North Bridge Venture Partners
5.89M
8.94%
--
--
Feb 28, 2025
BlackRock Institutional Trust Company, N.A.
3.08M
4.68%
+98.60K
+3.31%
Dec 31, 2024
The Vanguard Group, Inc.
1.79M
2.71%
+8.16K
+0.46%
Dec 31, 2024
Samsara BioCapital, LLC
1.97M
2.98%
-814.57K
-29.30%
Dec 31, 2024
Ikarian Capital LLC
1.06M
1.61%
+1.32K
+0.12%
Dec 31, 2024
Geode Capital Management, L.L.C.
885.97K
1.34%
+117.58K
+15.30%
Dec 31, 2024
Nantahala Capital Management, LLC
628.07K
0.95%
+628.07K
--
Sep 30, 2024
Two Sigma Investments, LP
595.50K
0.9%
-147.35K
-19.84%
Dec 31, 2024
Waksal (Harlan W)
536.97K
0.82%
+275.00K
+104.98%
Feb 28, 2025
查看更多
持股ETF
更新時間: 5 小時前
更新時間: 5 小時前
機構名稱
佔比
ProShares Hedge Replication ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
0%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Growth ETF
0%
查看更多
ProShares Hedge Replication ETF
佔比0%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
iShares Micro-Cap ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Proshares Ultra Russell 2000
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
